Pharmaceutical care of coronary heart disease with atrial fibrillation in one case
10.13699/j.cnki.1001-6821.2015.04.020
- VernacularTitle:心房颤动合并冠心病患者的药学监护
- Author:
Jia-Na SHI
1
;
Yong YUAN
;
Dan-Yan ZHU
Author Information
1. 浙江省立同德医院药剂科
- Keywords:
pharmaceutical care;
atrial fibrillation;
coronary heart disease;
anticoagulant;
interaction
- From:
The Chinese Journal of Clinical Pharmacology
2015;(4):304-305
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the pharmaceutical care points and standardized model for patients with cardiac fibrillation and coronary disease.Methods The specific medication in one case of patient with cardiac fibrillation and coronary disease was regarded as a breakthrough point.Utilizing knowledge of drug inter-reactions and adverse drug re-actions, clinical pharmacists participated in the decision of treatment re-gime and the performance of pharmaceutical care.Results and Conclu-sion Complex medication would be adopted for patients with cardiac fi-brillation and coronary disease usually.Clinical pharmacists should focus on drug inter-reactions and monitor adverse drug reactions, as well as the anti-coagulant regimen.For pharmaceutical education, warfarin and the second grade of prevention of coronary disease would be primary.
